APA (7th ed.) Citation

Bixby, D., Noppeney, R., Lin, T. L., Cortes, J., Krauter, J., Yee, K., . . . Colburn, D. (2019). Safety and efficacy of vismodegib in relapsed/refractory acute myeloid leukaemia: Results of a phase Ib trial. British journal of haematology, 185(3), . https://doi.org/10.1111/bjh.15571

Chicago Style (17th ed.) Citation

Bixby, Dale, et al. "Safety and Efficacy of Vismodegib in Relapsed/refractory Acute Myeloid Leukaemia: Results of a Phase Ib Trial." British Journal of Haematology 185, no. 3 (2019). https://doi.org/10.1111/bjh.15571.

MLA (9th ed.) Citation

Bixby, Dale, et al. "Safety and Efficacy of Vismodegib in Relapsed/refractory Acute Myeloid Leukaemia: Results of a Phase Ib Trial." British Journal of Haematology, vol. 185, no. 3, 2019, https://doi.org/10.1111/bjh.15571.